We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Safety Advisers Propose Regional Adverse-Event Reporting
FDA Safety Advisers Propose Regional Adverse-Event Reporting
May 31, 2005
The FDA shouldn’t abandon its current passive system for monitoring adverse drug events, according to FDA drug safety advisers, who recommended that the system could be improved by creating regional reporting centers, focusing resources on more promising data sets and requiring mandatory reporting by physicians.